Clinical resource
Respiratory non-small cell lung cancer definitive stereotactic EBRT peripheral tumours (eviQ ID 3389)
eviQ, Cancer Institute NSW
DoseLab summary
Endorsed eviQ protocol for peripheral lung SABR. DoseLab's Lung SBRT constraint table reproduces selected values from its organs-at-risk table, keeping eviQ's citation for each. Check the live page for the current version.
Why this is useful
A clinical protocol that lists one to three constraints per organ for each peripheral SBRT schedule, with every value footnoted to its primary source (RTOG 0915, TROG SAFRON II, TROG CHISEL, UK consensus).
Reference details
- Title
- Respiratory non-small cell lung cancer definitive stereotactic EBRT peripheral tumours (eviQ ID 3389)
- Authors / organization
- eviQ, Cancer Institute NSW
- Publication / protocol
- eviQ Radiation Oncology protocol 3389
- Version
- v.3 — last reviewed 16 March 2023; review due 30 June 2027
- Year
- 2023
- DOI
- Pending verification
- Disease sites
- Lung
- Topics
- SBRT, Dose Constraints, Peripheral tumors, Protocols
- Fractionation context
- SBRT: 30–34 Gy/1 fx, 48 Gy/4 fx, 54 Gy/3 fx
- Last reviewed by DoseLab
- 2026-09-22